Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CUBI - |
RCV003330107 | SCV004037107 | likely pathogenic | not provided | criteria provided, single submitter | not provided | ||
Institute for Medical Genetics and Human Genetics, |
RCV003330107 | SCV004037115 | likely pathogenic | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003408224 | SCV004108522 | likely pathogenic | ITPR3-related disorder | 2023-05-19 | criteria provided, single submitter | clinical testing | The ITPR3 c.7570C>T variant is predicted to result in the amino acid substitution p.Arg2524Cys. This variant has been documented as de novo in a patient with childhood onset Charcot-Marie-Tooth disease (CMT) (Patient P5 in Rönkkö et al 2020. PubMed ID: 32949214) and in the compound heterozygous state in a patient presenting with combined immunodeficiency and CMT (Patient P1 in Neumann et al. 2022. PubMed ID: 36302985). Functional studies of fibroblasts isolated from the patient described in Neumann et al. showed a disruption of channel function and calcium signaling. However, due to the compound heterozygous finding in this patient, analysis of the individual contribution of p.Arg2524Cys to the biological defect was not examined (Neumann et al. 2022. PubMed ID: 36302985). An additional functional analysis of the p.Arg2524Cys variant within a cell line lacking other endogenous IP3R isoforms and ITPR3 variants showed that the protein was non-functional (Terry et al. 2022. PubMed ID: 36444295). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. |
OMIM | RCV002305678 | SCV002599088 | pathogenic | Charcot-Marie-Tooth disease, demyelinating, type 1J | 2022-11-03 | no assertion criteria provided | literature only | |
Division Of Personalized Genomic Medicine, |
RCV002305678 | SCV004037367 | uncertain significance | Charcot-Marie-Tooth disease, demyelinating, type 1J | 2020-11-05 | flagged submission | clinical testing | The c.7570C>T variant is a single basepair substitution in exon 55 of 58 of the ITPR3 gene, which causes a substitution of the highly conserved arginine to cysteine at position 2524 (2524 of 2672) in the channel pore of transmembrane domain. Pathogenic variants localized in the channel pore of this transmembrane are predicted to affect the channel properties and/or the ion flux directly [PMID:32949214]. In silico analysis (including PolyPhen-2, SIFT and PROVEAN) consistently predict this variant to have a damaging effect on protein structure and/or function. This variant has not been observed in the Genome Aggregation Database (gnomAD) and is absent from ClinVar. [accessed 10/20/2020] ITPR3 encodes inositol 1,4,5-triphosphate receptor, type 3 which is involved in the mobilization of intracellular calcium [MIM#147267] The ITPR3 gene has not been reported to be associated with Mendelian disease in the OMIM database (accessed 10/20/2020). However, several articles have reported missense variants in this gene in cohorts of patients with Charcot-Marie-Tooth disease and hereditary sensory motor neuropathy (PMIDs: 27549087;24627108, 32949214). |